Breaking News
November 19, 2018 - Short Interpregnancy Intervals Tied to Adverse Outcome Risk
November 19, 2018 - New mothers’ breastfeeding pain can affect infant health
November 19, 2018 - Stanford Medicine magazine reports on ways digital technology is transforming health care | News Center
November 19, 2018 - Human drugs alter cricket personality
November 19, 2018 - Insilico Medicine to introduce ‘Cure a disease in a year’ program at Biodata World Congress 2018
November 19, 2018 - Experts debate over whether gut or brain is more important in regulating appetite
November 19, 2018 - Playing on fear and fun, hospitals follow pharma in direct-to-consumer advertising
November 19, 2018 - Low-Carb Diets May Work By Boosting Calorie Burn
November 19, 2018 - Key molecule responsible for learning and memory discovered
November 19, 2018 - New blood test developed for early diagnosis of ovarian cancer
November 19, 2018 - Researchers identify molecule to fight myotubular myopathy
November 19, 2018 - New solution to stop spread of brain cancer
November 19, 2018 - Immune cells trigger OCD-like behaviour in multiple sclerosis, study finds
November 19, 2018 - Scientists equip new virus that kills carcinoma cells with protein
November 19, 2018 - Novel approach could provide painless, efficient alternative for treating eye diseases
November 19, 2018 - Protein in cell membranes of sperm plays key role in finding their way to eggs
November 19, 2018 - Parents who decline flu vaccination for their child may be exposed to limited information
November 19, 2018 - Mirati Presents Data From Ongoing Phase 2 Clinical Trial Of Mocetinostat In Combination With Durvalumab At The SITC 33rd Annual Meeting
November 19, 2018 - FDA warns of common diabetes meds’ link to dangerous genital infection
November 19, 2018 - New methods for preserving shoulder function, quality of life in breast cancer patients
November 19, 2018 - Surprising discovery about BH4 may rekindle interest in once-promising pathway
November 19, 2018 - Nabriva Therapeutics Completes Submission of New Drug Application to U.S. Food and Drug Administration for Intravenous Contepo to Treat Complicated Urinary Tract Infections
November 19, 2018 - Beating breast cancer only to die of opioid use – a sad Appalachian story
November 19, 2018 - Workplace bullying or violence linked to higher risk of cardiovascular problems
November 19, 2018 - Changes in Risk Indicators of MetS Severity Tied to T2DM Risk
November 19, 2018 - ‘Game-changing’ skin sensor could improve life for a million hydrocephalus patients
November 19, 2018 - Alcohol ads on social media sites with pro-drinking comments increase desire to drink
November 19, 2018 - Neural networks could replace marker genes in RNA sequencing
November 19, 2018 - Obese adolescents feel less food enjoyment than those with normal weight, study reveals
November 18, 2018 - Goodbye ‘Gluten-Free’? Celiac Disease Vaccine May Make It Possible
November 18, 2018 - Skin ages when the main cells in the dermis lose their identity and function
November 18, 2018 - Rainforest vine compound makes pancreatic cancer cells susceptible to nutrient starvation
November 18, 2018 - A new mechanism in the control of inflammation
November 18, 2018 - Age-related decline in abstract reasoning ability predicts depressive symptoms over time
November 18, 2018 - Scientists succeed in increasing stability, biocompatibility of light-transducing nanoparticles
November 18, 2018 - Sugar, a ‘sweet’ tool to understand brain injuries
November 18, 2018 - Pharmacist-Led Effort Cuts Inappropriate Rx in Older Adults
November 18, 2018 - Novel discovery could lead to new cancer, autoimmune disease therapy
November 18, 2018 - AHA and ADA launch new initiative to help people with type 2 diabetes reduce heart disease risk
November 18, 2018 - Balanced production of pro and anti-inflammatory cytokines at two years of age protects against malaria
November 18, 2018 - New pharmacological agent shows promise for prevention of heart rhythm disorders
November 18, 2018 - All That Social Media May Boost Loneliness, Not Banish It
November 18, 2018 - Scientists shine new light on link between obesity and cancer
November 18, 2018 - Risk factors for cardiovascular disease closely track with changes in diet patterns
November 18, 2018 - Biogen Scoops Sixth Prix Galien Award with UK Win for Life-Changing Rare Disease Medicine
November 18, 2018 - Detectable HIV-1 in treated human liver cells found to be inert
November 18, 2018 - Using light to control crucial step in embryonic development
November 18, 2018 - Unusual case of father-to-son HIV transmission reported
November 18, 2018 - FDA Approves Aemcolo (rifamycin) to Treat Travelers’ Diarrhea
November 18, 2018 - Poverty blamed on widening north-south gap in young adult deaths in England
November 18, 2018 - Progress in meningitis lags far behind other vaccine-preventable diseases, analysis shows
November 18, 2018 - Consensus Statement Issued on Management of Foot, Ankle Gout
November 18, 2018 - Fine particle air pollution is a public health emergency hiding in plain sight
November 18, 2018 - In-hospital mortality higher among patients with drug-resistant infections
November 17, 2018 - Research shines new, explanatory light on link between obesity and cancer
November 17, 2018 - FIND explores new diagnostic assays for confirmatory HCV diagnosis in community settings
November 17, 2018 - Tracking Preemies’ Head Size May Yield IQ Clues
November 17, 2018 - Scientists call for unified standards in 3-D genome and epigenetic data
November 17, 2018 - Lab Innovations 2018 has beaten all records by attracting 3,113 attendees
November 17, 2018 - New strategy to hinder emergence of antimicrobial-resistant pathogens
November 17, 2018 - Sexuality education before age 18 may reduce risk of sexual assault in college
November 17, 2018 - Reducing cellular proliferation could help deplete HIV reservoir and lead to a functional cure
November 17, 2018 - New model of FSHD could be useful to study effectiveness of experimental therapeutics
November 17, 2018 - FDA approves antibacterial drug to treat travelers’ diarrhea
November 17, 2018 - Lab Innovations 2018 confirmed as a major hit with visitors, exhibitors and speakers
November 17, 2018 - Largest parasitic worm genetic study hatches novel treatment possibilities
November 17, 2018 - UCLA biologists uncover how head injuries can lead to serious brain disorders
November 17, 2018 - Static and dynamic physical activities offer varying protection against heart disease
November 17, 2018 - Obesity significantly increases risk of Type 2 diabetes and coronary artery disease
November 17, 2018 - New method to analyze cell membrane complexes could revolutionize the way we study diseases
November 17, 2018 - Researchers show how proteins interact in hypoxic conditions to facilitate mitochondrial fission
November 17, 2018 - People with rare cancers can benefit from genomic profiling, shows research
November 17, 2018 - NIH awards over $1.8 million to husband-and-wife doctors to test new breast cancer approach
November 17, 2018 - Four-in-one antibody used to fight flu shows promise in mice
November 17, 2018 - New approach allows pathogens to be starved by blocking important enzymes
November 17, 2018 - Higher body mass index could cause depression even without health problems
November 17, 2018 - Protein which plays role in sensing cell damage serves as new target to treat pulmonary hypertension
November 17, 2018 - FDA Approves Adcetris (brentuximab vedotin) in Combination with Chemotherapy for Adults with Previously Untreated Systemic Anaplastic Large Cell Lymphoma or Other CD30-Expressing Peripheral T-Cell Lymphomas
November 17, 2018 - ID specialist input improves outcomes for outpatient parenteral antimicrobial therapy
November 17, 2018 - UT Southwestern scientists selected to receive 2019 Edith and Peter O’Donnell Awards
Cryo-electron microscopy helps study proteins responsible for amyloid-based diseases

Cryo-electron microscopy helps study proteins responsible for amyloid-based diseases

image_pdfDownload PDFimage_print

The century old mission to understand how the proteins responsible for amyloid-based diseases such as Alzheimer’s, Huntingdon’s and Parkinson’s work has taken major steps forward in the last 12 months, thanks to a revolution in a powerful microscopy technique used by scientists.

High-powered microscopes using electrons instead of light to ‘see’ the actual shape of samples put under them, at near atomic-levels of detail, have only recently become available to UK scientists.

The UK has invested heavily in the ‘game-changing’ cryo-electron microscopes, but there are still fewer than 25 of the multi-million pound instruments in UK universities and research institutes.

The two instruments at the University of Leeds, funded by the University itself and Wellcome, are the only ones of their kind in the north of England.

They have already proved their worth as a key tool for scientists who have used them in a number of research projects, but have just delivered their biggest success yet: to reveal the structure of amyloid – a build-up of abnormal proteins in the body that causes disease.

There are less than 10 good quality images and structures of these kinds of proteins available to study in the world, so the Leeds’ research makes a significant contribution to scientists’ understanding of how proteins form aggregates and how they might contribute to amyloid disease.

The images and 3D structures of the protein aggregates – which the Leeds scientists showed formed long, twisted fibres – has been published in the journal Nature Communications. The protein involved- β2-microglobulin – is normally involved in a healthy immune system, but can assemble into the pain-causing amyloid fibres in people who undergo long term dialysis for kidney failure. When they lodge in people’s joints they can cause osteoarthritis

It is anticipated the findings will be used by drug manufacturers and research groups internationally who strive to fund cures for amyloid diseases of all types.

Professor Sheena Radford FMedSci, FRS and Professor Neil Ranson from the University’s Astbury Centre for Structural Molecular Biology, led the five year programme to image the protein fibres and show their 3-D structure.

The pair were supported by colleagues at Leeds, Josh Boardman, who at the time was an undergraduate student in Biochemistry.

The study also involved a long-standing collaboration with Professor Bob Griffin, from the Massachusetts Institute for Technology, who specialises in another method of advanced biological analysis of biological matter- solid- state nuclear magnetic resonance.

Professor Radford said: “Over the past six decades since the first electron microscopy pictures of amyloid were created, scientists have progressed from working with blurred low-resolution images to our razor sharp 3D images and structures, thanks to modern advances in cryo-electron microscopy.

“Now we know exactly where each kink and point is on the protein, we may be able to develop compounds which lock tightly to it, or disrupt it, and find out how the fibres contribute to disease. It’s the equivalent of going from trying to make two balloons stick together to having two cogs rotating perfectly with each other.

She added: “We’ve used cryo-electron microscopy not only to uncover the shape and structure of amyloid proteins, but also how they grow and intertwine with each other like the stands in a rope to form larger assemblies. This knowledge is going to be crucial for knowing how to deal with them.”

Professor Ranson said: “Until a year or so ago, scientists knew the structure looked more or less like a ladder, but we have now shown it is much more complex than that. We’re now beginning to see how different proteins folded up into different shapes and how those vary with every disease they cause.

“The extra detail we have uncovered means we can start to understand these proteins’ disease-causing abilities.

He added “Amyloid fibres are also known to have the strength of steel, and, now we understand their structures.we might be able to make new biomaterials inspired by their structures. This is a great example of where cryo-electron microscopy can have added advantages.”

Knowing the structure of the protein in the level of detail the Leeds researchers have provided, and measuring those differences in different types of amyloid disease and different patients, could also allow doctors to show who would be most at risk, meaning treatment can be targeted to those who need it most.

The next step for the science community is to begin identifying and developing inhibitors’ – compounds which can control protein assembly into amyloid. Professor Radford has secured almost £2million from Wellcome to carry out this stage of development.

Further lab trials, clinical trials, regulatory approval and the involvement of a drug developer would still be required before drugs could be brought to market, but the significant steps forward in image clarity and understanding of the amyloid folding structure mark a major leap forward.

Tagged with:

About author

Related Articles